Unlocking the Power of CBD-Infused Dog Biscuits: How This Trend is Transforming Pet Health and What Every Dog Owner Needs to Know. Discover the Science, Safety, and Future of CBD Treats for Your Furry Friend. (2025)

• Introduction: The Rise of CBD-Infused Dog Biscuits
• What is CBD? Understanding Cannabidiol for Pets
• How CBD-Infused Biscuits Work in Canine Bodies
• Key Benefits: Anxiety, Pain Relief, and Beyond
• Safety, Dosage, and Regulatory Guidelines
• Leading Brands and Product Innovations
• Veterinary Perspectives and Official Recommendations
• Market Growth: Trends and Public Interest (Estimated 25% Annual Growth, 2024-2028)
• Consumer Experiences and Case Studies
• Future Outlook: Technology, Research, and Evolving Regulations
• Sources & References

Introduction: The Rise of CBD-Infused Dog Biscuits

The market for CBD-infused dog biscuits has experienced remarkable growth in recent years, reflecting broader trends in both the pet care and wellness industries. Cannabidiol (CBD), a non-psychoactive compound derived from hemp, has gained significant attention for its potential therapeutic benefits in humans and animals alike. As of 2025, CBD-infused pet products—especially dog biscuits—are increasingly visible on store shelves and online platforms, driven by rising consumer interest in natural alternatives for pet health and wellness.

This surge is closely linked to evolving regulatory landscapes and growing scientific inquiry. In the United States, the 2018 Farm Bill federally legalized hemp-derived CBD containing less than 0.3% THC, paving the way for a proliferation of CBD products for both humans and animals. However, the U.S. Food and Drug Administration (FDA) maintains that CBD is not yet approved as a food additive for animals, and continues to monitor and issue guidance on its use. Despite this, many companies have launched CBD-infused dog biscuits, often emphasizing quality control, third-party testing, and compliance with state-level regulations.

Major pet industry players and specialized CBD brands have entered the market, reflecting confidence in the category’s growth potential. Organizations such as the American Veterinary Medical Association (AVMA) have acknowledged the increasing interest among pet owners and veterinarians, while also calling for more research and regulatory clarity. Recent surveys indicate that a significant proportion of pet owners are open to trying CBD products for their dogs, particularly for issues such as anxiety, pain, and inflammation.

Looking ahead to the next few years, the outlook for CBD-infused dog biscuits remains optimistic but contingent on several factors. Ongoing research into the safety and efficacy of CBD for pets is expected to inform future regulatory decisions and product development. The FDA and other authorities are anticipated to provide clearer guidelines, which could further legitimize the market and encourage innovation. Meanwhile, consumer demand for natural, functional pet treats is likely to persist, supporting continued expansion of CBD-infused dog biscuits as a mainstream wellness option for dogs.

What is CBD? Understanding Cannabidiol for Pets

Cannabidiol (CBD) is a naturally occurring compound found in the Cannabis sativa plant, distinct from tetrahydrocannabinol (THC), the psychoactive component responsible for the “high” associated with marijuana. In recent years, CBD has gained significant attention for its potential therapeutic benefits in both humans and animals, including dogs. As of 2025, the use of CBD in pet products—particularly in the form of dog biscuits—continues to expand, driven by growing consumer interest and evolving regulatory landscapes.

CBD interacts with the endocannabinoid system (ECS), a complex cell-signaling system present in mammals, which plays a role in regulating physiological processes such as pain, mood, appetite, and immune response. In dogs, the ECS is believed to function similarly to that in humans, providing a scientific rationale for exploring CBD’s effects on canine health. Research into CBD’s safety and efficacy for pets is ongoing, with preliminary studies suggesting potential benefits for conditions such as anxiety, osteoarthritis, and certain types of pain. However, the U.S. Food and Drug Administration (FDA) has not yet approved any CBD products specifically for animal use, and continues to monitor the market for safety and compliance.

CBD-infused dog biscuits are formulated to deliver a controlled dose of cannabidiol in a palatable, convenient form. These products typically use hemp-derived CBD, which contains less than 0.3% THC, in compliance with the 2018 Farm Bill in the United States. As of 2025, several veterinary organizations, including the American Veterinary Medical Association (AVMA), emphasize the importance of quality control, accurate labeling, and ongoing research to ensure the safety of CBD products for pets. The AVMA has called for more robust clinical trials and regulatory clarity, reflecting the cautious optimism within the veterinary community.

Looking ahead, the outlook for CBD-infused dog biscuits is shaped by increasing consumer demand, ongoing scientific investigation, and anticipated regulatory developments. The FDA and state-level agencies are expected to provide further guidance on the use of CBD in pet products, which may influence product formulations, labeling requirements, and veterinary recommendations. As research progresses and regulations evolve, pet owners and veterinarians will have access to more evidence-based information to guide the safe and effective use of CBD-infused dog biscuits for canine health and wellness.

How CBD-Infused Biscuits Work in Canine Bodies

CBD-infused dog biscuits are designed to deliver cannabidiol (CBD), a non-psychoactive compound derived from the hemp plant, in a palatable and convenient form for canine consumption. As of 2025, the understanding of how CBD interacts with canine physiology is grounded in the study of the endocannabinoid system (ECS), a complex cell-signaling network present in all mammals, including dogs. The ECS plays a crucial role in regulating processes such as pain sensation, mood, appetite, and immune response.

When a dog consumes a CBD-infused biscuit, the CBD is absorbed through the digestive tract and enters the bloodstream. From there, it interacts primarily with the ECS’s CB1 and CB2 receptors. CB1 receptors are mainly found in the brain and central nervous system, while CB2 receptors are more prevalent in peripheral organs and immune cells. By modulating these receptors, CBD is believed to help maintain homeostasis and potentially alleviate symptoms related to anxiety, inflammation, pain, and certain neurological disorders.

Recent studies, including those referenced by the American Veterinary Medical Association (AVMA), indicate that CBD may have therapeutic potential for dogs, particularly in managing osteoarthritis-related pain and seizure frequency in certain epileptic conditions. However, the AVMA and other veterinary authorities emphasize that while preliminary data is promising, more large-scale, controlled clinical trials are needed to fully understand efficacy, optimal dosing, and long-term safety.

The bioavailability of CBD in biscuit form is a key consideration. Oral administration, such as through biscuits, typically results in lower and slower absorption compared to tinctures or oils placed directly in the mouth. This means effects may take longer to manifest—often 30 to 90 minutes after ingestion—and may be less pronounced. Nevertheless, biscuits offer a practical and stress-free method for pet owners to administer CBD, especially for dogs that are averse to other delivery methods.

As regulatory frameworks evolve, organizations like the U.S. Food and Drug Administration (FDA) continue to monitor the safety and marketing of CBD products for animals. The FDA has issued caution regarding unsubstantiated health claims and the importance of product quality and accurate labeling. Looking ahead, ongoing research and regulatory developments are expected to shape the landscape for CBD-infused dog biscuits, with a focus on ensuring both efficacy and safety for canine companions.

Key Benefits: Anxiety, Pain Relief, and Beyond

CBD-infused dog biscuits have gained significant attention in 2025 as pet owners increasingly seek natural alternatives to support their dogs’ well-being. The primary benefits associated with these products are anxiety reduction, pain relief, and broader wellness support, reflecting both ongoing research and evolving veterinary practices.

Anxiety in dogs—manifesting as separation anxiety, noise phobias, or general stress—remains a leading concern for pet owners. Recent studies and anecdotal reports suggest that cannabidiol (CBD), a non-psychoactive compound derived from hemp, may help modulate the endocannabinoid system in dogs, potentially reducing anxiety-related behaviors. The American Veterinary Medical Association (AVMA), a leading authority in veterinary medicine, acknowledges growing interest in CBD for pets and highlights the need for further research, but notes that early evidence and owner reports are promising for anxiety management.

Pain relief is another key area where CBD-infused dog biscuits are being utilized. Dogs suffering from osteoarthritis, chronic pain, or post-surgical discomfort may benefit from the anti-inflammatory properties of CBD. The U.S. Food and Drug Administration (FDA) has not yet approved CBD for veterinary use, but ongoing clinical trials and pilot studies are exploring its efficacy and safety. In 2025, several veterinary schools and research institutions are conducting controlled studies to better understand dosing, safety, and long-term effects, with preliminary results indicating potential for pain management, especially in older dogs.

Beyond anxiety and pain, pet owners and veterinarians are exploring additional benefits of CBD-infused dog biscuits, such as appetite stimulation, support for dogs with epilepsy, and general wellness. The American Kennel Club (AKC), a prominent dog registry and advocacy organization, provides educational resources on CBD and notes that while evidence is still emerging, some owners report improvements in mobility, sleep, and overall quality of life.

Looking ahead, the outlook for CBD-infused dog biscuits is shaped by ongoing research, evolving regulations, and increasing consumer demand. As more data becomes available and regulatory frameworks adapt, it is expected that veterinarians will have clearer guidelines for recommending these products. The next few years are likely to see expanded clinical trials, improved product standardization, and greater integration of CBD-infused treats into holistic pet care regimens.

Safety, Dosage, and Regulatory Guidelines

The safety, dosage, and regulatory landscape for CBD-infused dog biscuits is evolving rapidly in 2025, reflecting both growing consumer interest and ongoing scientific inquiry. Cannabidiol (CBD), a non-psychoactive compound derived from hemp, is increasingly incorporated into pet treats, with dog biscuits being a leading format. However, questions about safety, appropriate dosing, and regulatory oversight remain central to the sector’s development.

In terms of safety, recent studies and position statements from veterinary authorities emphasize the need for caution. The American Veterinary Medical Association (AVMA) acknowledges anecdotal reports of CBD’s potential benefits for canine anxiety and pain, but also highlights the lack of long-term safety data and the risk of adverse effects such as gastrointestinal upset or drug interactions. The U.S. Food and Drug Administration (FDA) continues to monitor adverse event reports and has issued warnings about unsubstantiated health claims and inconsistent product quality in the pet CBD market.

Dosage remains a complex issue. There is no universally accepted dosing standard for CBD in dogs, and the optimal amount can vary based on the animal’s weight, age, health status, and the specific condition being addressed. The AVMA and the FDA both recommend that pet owners consult with veterinarians before administering CBD products. Some manufacturers are beginning to standardize dosing instructions based on emerging research, but variability persists across brands and products.

Regulatory guidelines are in flux. As of 2025, the FDA has not approved any CBD products for animal use, and the agency maintains that it is illegal to market CBD in food or dietary supplements for animals. However, enforcement is uneven, and several states have enacted their own regulations permitting or restricting the sale of CBD-infused pet products. The U.S. Department of Agriculture (USDA) oversees hemp cultivation, but does not regulate finished pet products. Industry groups, such as the National Animal Supplement Council (NASC), have established voluntary quality standards and labeling guidelines to promote product safety and transparency.

Looking ahead, the outlook for CBD-infused dog biscuits will likely be shaped by ongoing research, evolving state and federal regulations, and increased collaboration between industry and veterinary professionals. As more data emerges and regulatory clarity improves, standardized safety and dosage guidelines are expected to become more widely adopted, supporting responsible innovation in this fast-growing segment.

Leading Brands and Product Innovations

The market for CBD-infused dog biscuits continues to evolve rapidly in 2025, driven by growing consumer interest in pet wellness and ongoing regulatory developments. Several leading brands have established themselves as innovators in this space, focusing on product quality, transparency, and scientific backing.

One of the most prominent players is Elixinol, a company with a longstanding reputation in the hemp-derived CBD sector. Elixinol has expanded its pet product line to include dog biscuits formulated with broad-spectrum CBD, emphasizing third-party lab testing and clear labeling of cannabinoid content. Their commitment to quality assurance and traceability has helped set industry standards.

Another key brand is Charlotte’s Web, known for its vertically integrated supply chain and proprietary hemp genetics. In 2025, Charlotte’s Web continues to innovate with new flavors and functional ingredients in their CBD dog biscuits, such as formulations targeting joint health or calming effects. The company’s products are developed in consultation with veterinary professionals and are subject to rigorous quality controls.

Emerging brands are also making significant contributions. Canna-Pet has introduced biscuits with enhanced bioavailability, utilizing novel delivery systems to improve absorption of CBD in dogs. Their research collaborations with veterinary schools and animal health organizations underscore a commitment to evidence-based product development.

Product innovation in 2025 is characterized by a focus on functional benefits, such as biscuits designed for specific health concerns (e.g., anxiety, mobility, skin health). Brands are increasingly incorporating additional active ingredients like glucosamine, omega-3 fatty acids, and herbal extracts to create multi-functional treats. Packaging innovations, such as resealable and recyclable materials, reflect growing consumer demand for sustainability.

Regulatory clarity remains a work in progress. The U.S. Food and Drug Administration (FDA) continues to monitor the CBD pet product market, issuing guidance and warning letters as needed. Leading brands are proactively engaging with the FDA and industry groups to advocate for clear standards and responsible marketing practices.

Looking ahead, the outlook for CBD-infused dog biscuits is positive, with anticipated growth driven by increased pet ownership, greater acceptance of CBD, and ongoing product innovation. As scientific research expands and regulatory frameworks mature, leading brands are expected to further differentiate themselves through transparency, safety, and efficacy.

Veterinary Perspectives and Official Recommendations

In 2025, veterinary perspectives on CBD-infused dog biscuits remain cautious but increasingly informed by emerging research and regulatory developments. The use of cannabidiol (CBD) in pet products, including dog biscuits, has grown rapidly, prompting veterinary organizations and regulatory bodies to issue updated guidance and recommendations.

The American Veterinary Medical Association (AVMA), representing over 99,500 veterinarians in the United States, continues to emphasize the need for more robust clinical evidence regarding the safety and efficacy of CBD in companion animals. As of early 2025, the AVMA acknowledges anecdotal reports of benefits for conditions such as anxiety and osteoarthritis in dogs, but it maintains that peer-reviewed, large-scale studies are still limited. The AVMA advises veterinarians to remain informed about state and federal regulations and to discuss potential risks and benefits with pet owners transparently.

The U.S. Food and Drug Administration (FDA) has not approved any CBD products for use in animals, including dog biscuits, as of 2025. The FDA continues to monitor the marketplace for unsubstantiated health claims and potential safety concerns, issuing warning letters to companies that violate federal law. The agency encourages veterinarians and pet owners to report adverse events associated with CBD-infused products through its Safety Reporting Portal. The FDA also highlights the need for standardized manufacturing practices and accurate labeling to ensure product consistency and safety.

Internationally, the World Small Animal Veterinary Association (WSAVA), a global body representing veterinary professionals, has called for harmonized research efforts and regulatory frameworks to address the growing use of CBD in pet nutrition and therapeutics. The WSAVA’s 2024 position statement urges caution, recommending that veterinarians rely on evidence-based guidance and prioritize animal welfare when considering CBD-infused treats.

Looking ahead, the outlook for CBD-infused dog biscuits in veterinary practice is expected to evolve as ongoing clinical trials and toxicology studies yield new data. Several universities and veterinary research centers are conducting controlled studies to better understand dosing, pharmacokinetics, and long-term effects of CBD in dogs. Regulatory agencies are anticipated to update their recommendations as scientific consensus develops, potentially paving the way for more formalized guidelines and, eventually, product approvals.

In summary, while interest in CBD-infused dog biscuits continues to rise among pet owners, official veterinary recommendations in 2025 remain conservative, prioritizing safety, regulatory compliance, and the need for further research before widespread endorsement.

Market Growth: Trends and Public Interest (Estimated 25% Annual Growth, 2024-2028)

The market for CBD-infused dog biscuits is experiencing robust expansion, with industry estimates projecting an average annual growth rate of approximately 25% from 2024 through 2028. This surge is driven by a confluence of factors, including increased pet ownership, heightened awareness of pet wellness, and evolving regulatory landscapes that are gradually legitimizing cannabidiol (CBD) use in animal products.

In 2025, the United States remains the largest market for CBD pet products, with CBD-infused dog biscuits representing a significant and growing segment. The American Veterinary Medical Association (AVMA), a leading authority in veterinary medicine, has noted a marked rise in consumer inquiries and veterinary discussions regarding the use of CBD for canine anxiety, pain, and inflammation. While the AVMA maintains a cautious stance pending further research, its acknowledgment of the trend underscores the mainstreaming of CBD pet products.

Major pet product manufacturers and retailers are responding to this demand. Companies such as Mars, Incorporated—one of the world’s largest pet care companies—have expanded their product lines to include CBD-infused treats, reflecting both consumer interest and confidence in the category’s growth. Similarly, specialty pet retailers and e-commerce platforms are dedicating more shelf space and online visibility to these products, further fueling market expansion.

Public interest is also reflected in the increasing number of clinical studies and pilot programs. The U.S. Food and Drug Administration (FDA) continues to monitor the safety and efficacy of CBD in animal products, and while no CBD-infused dog biscuit has yet received formal FDA approval, the agency’s ongoing engagement signals a potential pathway for future regulatory clarity. This is expected to bolster consumer confidence and encourage further investment in research and product development.

Looking ahead, the outlook for CBD-infused dog biscuits remains highly positive. As regulatory frameworks evolve and scientific understanding deepens, the market is poised for continued double-digit growth. The intersection of pet wellness trends, consumer demand for natural remedies, and increasing product availability suggests that CBD-infused dog biscuits will become a staple in the pet care industry over the next several years.

Consumer Experiences and Case Studies

In 2025, consumer experiences with CBD-infused dog biscuits continue to shape the evolving landscape of pet wellness products. Pet owners increasingly report using these biscuits to address issues such as anxiety, joint discomfort, and age-related mobility challenges in their dogs. Anecdotal evidence, shared through veterinary clinics, online forums, and pet care communities, often highlights perceived improvements in canine behavior and comfort after regular administration of CBD treats.

A notable trend is the growing transparency among manufacturers regarding ingredient sourcing and third-party testing. Companies such as American Kennel Club (AKC) and American Veterinary Medical Association (AVMA) have published guidance for pet owners, emphasizing the importance of choosing products with clear labeling and certificates of analysis. This has led to a more informed consumer base, with many dog owners seeking out brands that provide detailed cannabinoid profiles and batch-specific lab results.

Case studies collected by veterinary professionals in 2024 and early 2025 illustrate a spectrum of outcomes. For example, some owners of senior dogs with osteoarthritis report observable improvements in mobility and willingness to exercise after several weeks of CBD biscuit supplementation. In contrast, a minority of cases note mild gastrointestinal upset or no discernible effect, underscoring the variability in individual responses and the need for careful dosing. The U.S. Food and Drug Administration (FDA) continues to monitor adverse event reports and has reiterated that while CBD is not yet approved for use in animals, ongoing data collection is essential for future regulatory decisions.

Veterinary clinics are increasingly documenting these consumer experiences through structured surveys and follow-up appointments. The American Veterinary Medical Association has encouraged practitioners to discuss CBD use openly with clients, fostering a collaborative approach to monitoring efficacy and safety. This dialogue is expected to yield more robust case data in the coming years, potentially informing clinical guidelines and best practices.

Looking ahead, the outlook for CBD-infused dog biscuits is shaped by both consumer demand and the gradual accumulation of real-world evidence. As more pet owners share their experiences and as veterinary oversight increases, the industry is likely to see further refinement in product quality and usage recommendations. The ongoing collection of case studies and consumer feedback will play a pivotal role in shaping regulatory frameworks and ensuring the safe integration of CBD products into canine wellness routines.

Future Outlook: Technology, Research, and Evolving Regulations

The future of CBD-infused dog biscuits is shaped by rapid technological advancements, ongoing research, and evolving regulatory frameworks. As of 2025, the pet wellness sector continues to see significant innovation in product formulation and delivery systems. Companies are investing in precision dosing technologies, such as microencapsulation, to enhance the bioavailability and stability of cannabidiol (CBD) in dog biscuits. These advancements aim to ensure consistent therapeutic effects and improved palatability for pets.

Research into the efficacy and safety of CBD for canine health is expanding. Several veterinary schools and research institutions are conducting controlled studies to better understand the impact of CBD on conditions such as anxiety, osteoarthritis, and epilepsy in dogs. For example, the American Veterinary Medical Association (AVMA) has highlighted the need for more peer-reviewed studies and is actively monitoring developments in cannabinoid research. Early findings suggest potential benefits, but researchers emphasize the importance of standardized dosing and long-term safety data.

On the regulatory front, 2025 marks a period of transition. In the United States, the U.S. Food and Drug Administration (FDA) maintains that CBD is not approved as a food additive for animals, but ongoing discussions and petitions from industry stakeholders are prompting the agency to reconsider its stance. The FDA is expected to issue updated guidance or a regulatory framework for CBD in pet products within the next few years, which could provide much-needed clarity for manufacturers and consumers alike.

Internationally, regulatory approaches vary. In Canada, the Government of Canada regulates CBD under the Cannabis Act, and only licensed producers can manufacture and sell CBD-infused pet products. The European Union is also reviewing its policies, with some member states allowing CBD pet treats under strict conditions, while others maintain prohibitions. These regulatory shifts are likely to influence global market access and product development strategies.

Looking ahead, the outlook for CBD-infused dog biscuits is cautiously optimistic. As scientific evidence accumulates and regulatory pathways become clearer, the market is expected to grow, driven by consumer demand for natural pet wellness solutions. However, the pace of adoption will depend on the outcomes of ongoing research, the establishment of safety standards, and the harmonization of regulations across jurisdictions. Industry leaders and veterinary organizations will play a crucial role in shaping best practices and ensuring the responsible integration of CBD into pet nutrition.

Sources & References

• American Veterinary Medical Association
• American Kennel Club
• American Veterinary Medical Association
• U.S. Department of Agriculture
• World Small Animal Veterinary Association
• Government of Canada